Tobradex ST

See also: Generic TobraDex

Tobradex ST is a brand name of dexamethasone/tobramycin ophthalmic, approved by the FDA in the following formulation(s):

TOBRADEX ST (dexamethasone; tobramycin - suspension/drops; ophthalmic)

• 
  Manufacturer: ALCON PHARMS LTD
  
  Approval date: February 13, 2009
  
  Strength(s): 0.05%;0.3% ^[RLD]

Has a generic version of Tobradex ST been approved?

No. There is currently no therapeutically equivalent version of Tobradex ST available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tobradex ST. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Topical ophthalmic compositions containing tobramycin and dexamethasone
  Patent 7,795,316
  Issued: September 14, 2010
  Inventor(s): Kabra; Bhagwati P.
  Assignee(s): Alcon Research, Ltd.
  Ophthalmic pharmaceutical compositions containing tobramycin, dexamethasone and deacetylated xanthan gum are described. The compositions provide longer ocular retention for enhanced ocular bioavailability of tobramycin and dexamethasone. In a preferred embodiment, the compositions also provide for improved suspension of dexamethasone. The concentration of ionizable species in the compositions is controlled so as to prevent precipitation of the xanthan gum as a result of ionic interactions between tobramycin and xanthan gum, while allowing for a restoration of viscosity upon topical application of the compositions to the eye. The use of deacetylated xanthan gum is disclosed, so as to avoid formulation instability caused by pH drift during storage.
  
  Patent expiration dates:
  
  
  • August 3, 2028
    
    ✓ 
    Patent use: USE OF A COMBINATION OF TOBRAMYCIN AND DEXAMETHASONE TO TREAT OCULAR INFLAMMATION WHERE AN INFECTION OR RISK OF INFECTION EXISTS
    ✓ 
    Drug product
  
  

See also...

• TobraDex ST Drops Consumer Information (Wolters Kluwer)
• Tobradex ST Advanced Consumer Information (Micromedex)
• Tobramycin/Dexamethasone Drops Consumer Information (Wolters Kluwer)
• Tobramycin/Dexamethasone Ointment Consumer Information (Wolters Kluwer)
• Tobramycin and dexamethasone ophthalmic Consumer Information (Cerner Multum)
• Tobramycin and dexamethasone Ophthalmic Advanced Consumer Information (Micromedex)